Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment

NCT00079183 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease

Interventions

DRUG: sirolimus

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]